Anivive Expands Specialty Sales Team to Support Rapid National Distribution of LAVERDIA™-CA1 (verdinexor)
06/28/2021 | 05:59pm EDT
Send by mail :
Message :
Required fields
LONG BEACH, Calif., June 28, 2021 /PRNewswire/ To meet demand and help veterinarians incorporate a novel treatment for canine lymphoma, Anivive has expanded its specialty sales team to increase availability for customers in 10 key markets. Anivive now has specialty sales executives in the following markets: New England, New York/New Jersey, Philadelphia, Baltimore, Southeast, Ohio Valley, Upper Midwest, Texas, Northern California and Southern California. Our sales executives and veterinarians have quickly become content experts in selective inhibitors of nuclear export [SINE] technology, the core mechanism of LAVERDIA-CA1, and are helping healthcare teams learn about all the various facets of this exciting new treatment, says Chad Dodd, DVM, Chief Commercial Officer at Anivive. LAVERDIA-CA1 gives us
Anivive Expands Specialty Sales Team to Support Rapid National Distribution of LAVERDIA™-CA1 (verdinexor) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.